{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase 2 Multiple Dose Study to Evaluate the Efficacy and Safety of PUL-042 Inhalation Solution in Reducing\nLower Respiratory Tract Complications in Patients with Hematologic Malignancies and Recipients of Hematopoietic\nStem Cell Transplantation (HSCT) with Documented Viral Infections with Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-2-multiple-dose-study-to-evaluate-the-efficacy-and-safety-of-pul-042-inhalation-solution-in-reducinglower-respiratory-tract-complications-in-patients-with-hematologic-malignancies-and-recipie\/#breadcrumbitem"}]}